IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 381 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $497,508 | +10.0% | 10,968 | -0.5% | 0.01% | +14.3% |
| Q2 2023 | $452,110 | +14.4% | 11,019 | -0.3% | 0.01% | +16.7% |
| Q1 2023 | $395,105 | +0.9% | 11,055 | +6.6% | 0.01% | 0.0% |
| Q4 2022 | $391,637 | -18.2% | 10,369 | -4.3% | 0.01% | -25.0% |
| Q3 2022 | $479,000 | +18.9% | 10,834 | -0.6% | 0.01% | +14.3% |
| Q2 2022 | $403,000 | -1.0% | 10,903 | -0.8% | 0.01% | +16.7% |
| Q1 2022 | $407,000 | +37.0% | 10,995 | +12.4% | 0.01% | +50.0% |
| Q4 2021 | $297,000 | -18.6% | 9,782 | -10.1% | 0.00% | -20.0% |
| Q3 2021 | $365,000 | -14.5% | 10,882 | +1.5% | 0.01% | -16.7% |
| Q2 2021 | $427,000 | -13.0% | 10,717 | -2.0% | 0.01% | -25.0% |
| Q1 2021 | $491,000 | -14.9% | 10,936 | +7.3% | 0.01% | -20.0% |
| Q4 2020 | $577,000 | +7.9% | 10,190 | -9.6% | 0.01% | 0.0% |
| Q3 2020 | $535,000 | -24.1% | 11,276 | -5.6% | 0.01% | -33.3% |
| Q2 2020 | $705,000 | +22.2% | 11,947 | -2.3% | 0.02% | +7.1% |
| Q1 2020 | $577,000 | -24.6% | 12,223 | -3.5% | 0.01% | -12.5% |
| Q4 2019 | $765,000 | -1.5% | 12,663 | -2.4% | 0.02% | -5.9% |
| Q3 2019 | $777,000 | -12.5% | 12,968 | -6.1% | 0.02% | -15.0% |
| Q2 2019 | $888,000 | -25.1% | 13,813 | -5.4% | 0.02% | -25.9% |
| Q1 2019 | $1,185,000 | +48.1% | 14,600 | -1.3% | 0.03% | +35.0% |
| Q4 2018 | $800,000 | +2.4% | 14,793 | -2.3% | 0.02% | +17.6% |
| Q3 2018 | $781,000 | -13.7% | 15,139 | -30.3% | 0.02% | -22.7% |
| Q2 2018 | $905,000 | -10.5% | 21,734 | -5.2% | 0.02% | -12.0% |
| Q1 2018 | $1,011,000 | -10.0% | 22,938 | +3.6% | 0.02% | -16.7% |
| Q4 2017 | $1,123,000 | 0.0% | 22,134 | 0.0% | 0.03% | +3.4% |
| Q3 2017 | $1,123,000 | +2.7% | 22,134 | +2.9% | 0.03% | -3.3% |
| Q2 2017 | $1,094,000 | +19.0% | 21,502 | -6.0% | 0.03% | +15.4% |
| Q1 2017 | $919,000 | – | 22,869 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |